Stay updated on EPIONE: Tradipitant vs. Placebo in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the EPIONE: Tradipitant vs. Placebo in Atopic Dermatitis Clinical Trial page.

Latest updates to the EPIONE: Tradipitant vs. Placebo in Atopic Dermatitis Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedA site-wide NIH announcement about transition updates and terminology has been removed from the page.SummaryDifference1%

- Check19 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0 while the study record still displays a 403 Forbidden error.SummaryDifference0.2%

- Check26 days agoChange DetectedA site-wide NIH banner announces a transition from “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.SummaryDifference1%

- Check33 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2, while the study page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check40 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check61 days agoChange DetectedThe page now shows a 403 Forbidden message and minimal HTML, replacing the study details and sponsor-related content with a simple header/footer.SummaryDifference17%

Stay in the know with updates to EPIONE: Tradipitant vs. Placebo in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EPIONE: Tradipitant vs. Placebo in Atopic Dermatitis Clinical Trial page.